EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Acidic pH Greatly Enhances Calbindin‐D28K's Inhibitory Effect on Caspase‐3: Implications for Alzheimer's Therapeutics

Jude Kinkead, Richele J Thompson, Morgan E Milton iD, John Cavanagh iD

Cell Biochemistry and Function · 2025-12 · 43 (12)

DOI: 10.1002/cbf.70157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, online erschienen am 23.12.2025. Verfasst von Jude Kinkead und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, North Carolina, Greenville, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Caspase 3, Calbindins, Calbindin 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wooten Family Initiative for Brain Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Alzheimer's disease (AD), the interaction between many AD‐relevant proteins, including amyloid precursor protein (APP) and tau, with the cysteine protease caspase‐3 (Cas3) enhances AD pathogenesis. Searching for effective Cas3 inhibitors, we turned to the sensor calbindin‐D28K (D28K) which specifically inhibits Cas3. The specific D28K conformation that elicits Cas3 inhibition remains elusive. To shed more light on this D28K conformation, we investigated likely environmental regulators. Recently, evidence of pH imbalance in aging brains has been implicated in AD pathologies. Using pull‐down assays, Cas3 inhibition assays, and molecular docking, we identified pH as a critical regulator for tuning the strength of D28K's inhibitory actions and subsequently identified Loop4 in Cas3 as the structural element targeted by D28K.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCaspase 3CalbindinsCalbindin 1HumansHydrogen-Ion ConcentrationMolecular Docking Simulation

Substanzen

Caspase 3CalbindinsCalbindin 1

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, North Carolina, Greenville, USA.

ORCID-Profile: Morgan E Milton, John Cavanagh

Förderung

  • Wooten Family Initiative for Brain Health Research

Zitieren

APA

Kinkead, J., Thompson, R. J., Milton, M. E., & Cavanagh, J. (2025). Acidic pH Greatly Enhances Calbindin‐D28K's Inhibitory Effect on Caspase‐3: Implications for Alzheimer's Therapeutics. Cell Biochemistry and Function, 43(12). https://doi.org/10.1002/cbf.70157

Vancouver

Kinkead J, Thompson RJ, Milton ME, Cavanagh J. Acidic pH Greatly Enhances Calbindin‐D28K's Inhibitory Effect on Caspase‐3: Implications for Alzheimer's Therapeutics. Cell Biochemistry and Function. 2025;43(12). doi:10.1002/cbf.70157

BibTeX
@article{Kinkead2025,
  author = {Kinkead, Jude and Thompson, Richele J and Milton, Morgan E and Cavanagh, John},
  title = {Acidic pH Greatly Enhances Calbindin‐D28K's Inhibitory Effect on Caspase‐3: Implications for Alzheimer's Therapeutics},
  journal = {Cell Biochemistry and Function},
  year = {2025},
  volume = {43},
  number = {12},
  doi = {10.1002/cbf.70157}
}
Kostenlos starten →